201 related articles for article (PubMed ID: 28183250)
21. [Targeted therapies and radiation therapy in non-small cell lung cancer].
Rivera S; Quéro L; Wong Hee Kam S; Maylin C; Deutsch E; Hennequin C
Cancer Radiother; 2011 Oct; 15(6-7):527-35. PubMed ID: 21885318
[TBL] [Abstract][Full Text] [Related]
22. Metastatic Colorectal Cancer: Role of Target Therapies and Future Perspectives.
Nappi A; Berretta M; Romano C; Tafuto S; Cassata A; Casaretti R; Silvestro L; Divitiis C; Alessandrini L; Fiorica F; Ottaiano A; Nasti G
Curr Cancer Drug Targets; 2018; 18(5):421-429. PubMed ID: 28183254
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic Antibodies in Cancer Therapy.
Gasser M; Waaga-Gasser AM
Adv Exp Med Biol; 2016; 917():95-120. PubMed ID: 27236554
[TBL] [Abstract][Full Text] [Related]
24. On target? Off target? Why we really do not know.
Leichman L
J Clin Oncol; 2010 Jun; 28(18):2937-8. PubMed ID: 20458025
[No Abstract] [Full Text] [Related]
25. Clinical development landscape in GIST: from novel agents that target accessory pathways to revisiting non-targeted therapies.
Sankhala KK
Expert Opin Investig Drugs; 2017 Apr; 26(4):427-443. PubMed ID: 28267385
[TBL] [Abstract][Full Text] [Related]
26. Pharmacological Profile and Pharmacogenomics of Anti-Cancer Drugs Used for Targeted Therapy.
Di Francia R; De Monaco A; Saggese M; Iaccarino G; Crisci S; Frigeri F; De Filippi R; Berretta M; Pinto A
Curr Cancer Drug Targets; 2018; 18(5):499-511. PubMed ID: 28183252
[TBL] [Abstract][Full Text] [Related]
27. Molecular targeted therapy for pancreatic adenocarcinoma: A review of completed and ongoing late phase clinical trials.
Mosquera C; Maglic D; Zervos EE
Cancer Genet; 2016 Dec; 209(12):567-581. PubMed ID: 27613577
[TBL] [Abstract][Full Text] [Related]
28. Molecular targets in GI malignancies - A pathologist's perspective.
Pawar S; Sharma A
Indian J Pathol Microbiol; 2021 Jun; 64(Supplement):S43-S51. PubMed ID: 34135137
[TBL] [Abstract][Full Text] [Related]
29. Personalised Treatment in Gastric Cancer: Myth or Reality?
Tarazona N; Gambardella V; Huerta M; Roselló S; Cervantes A
Curr Oncol Rep; 2016 Jul; 18(7):41. PubMed ID: 27215435
[TBL] [Abstract][Full Text] [Related]
30. Melatonin and gastrointestinal cancers: Current evidence based on underlying signaling pathways.
Pourhanifeh MH; Mehrzadi S; Kamali M; Hosseinzadeh A
Eur J Pharmacol; 2020 Nov; 886():173471. PubMed ID: 32877658
[TBL] [Abstract][Full Text] [Related]
31. Systemic treatment of neuroendocrine tumors with hepatic metastases.
Demirkan BH; Eriksson B
Turk J Gastroenterol; 2012; 23(5):427-37. PubMed ID: 23161287
[TBL] [Abstract][Full Text] [Related]
32. Lapatinib.
Voigtlaender M; Schneider-Merck T; Trepel M
Recent Results Cancer Res; 2018; 211():19-44. PubMed ID: 30069757
[TBL] [Abstract][Full Text] [Related]
33. Imatinib mesylate: in the treatment of gastrointestinal stromal tumours.
Croom KF; Perry CM
Drugs; 2003; 63(5):513-22; discussion 523-4. PubMed ID: 12600228
[TBL] [Abstract][Full Text] [Related]
34. The Role of Epidermal Growth Factor Receptor in the Management of Gastrointestinal Carcinomas: Present Status and Future Perspectives.
Mahmood MQ; Shukla SD; Dua K; Shastri MD
Curr Pharm Des; 2017; 23(16):2314-2320. PubMed ID: 28120720
[TBL] [Abstract][Full Text] [Related]
35. Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571).
Demetri GD
Eur J Cancer; 2002 Sep; 38 Suppl 5():S52-9. PubMed ID: 12528773
[TBL] [Abstract][Full Text] [Related]
36. Ramucirumab for the treatment of gastric cancers, colorectal adenocarcinomas, and other gastrointestinal malignancies.
Aprile G; Ferrari L; Cremolini C; Bergamo F; Fontanella C; Battaglin F; Rihawi K; Lonardi S; Loupakis F; Scartozzi M
Expert Rev Clin Pharmacol; 2016 Jul; 9(7):877-85. PubMed ID: 27149032
[TBL] [Abstract][Full Text] [Related]
37. Proteogenomics for the Study of Gastrointestinal Stromal Tumors.
Kondo T
Adv Exp Med Biol; 2016; 926():139-151. PubMed ID: 27686810
[TBL] [Abstract][Full Text] [Related]
38. [Gastrointestinal stromal tumors: a new model for target therapy].
Tonini G; Vincenzi B; La Cesa A
Clin Ter; 2003; 154(2):75-6. PubMed ID: 12856363
[No Abstract] [Full Text] [Related]
39. Aurora kinase A in gastrointestinal cancers: time to target.
Katsha A; Belkhiri A; Goff L; El-Rifai W
Mol Cancer; 2015 May; 14():106. PubMed ID: 25987188
[TBL] [Abstract][Full Text] [Related]
40. Beyond standard therapy: drugs under investigation for the treatment of gastrointestinal stromal tumor.
Alturkmani HJ; Pessetto ZY; Godwin AK
Expert Opin Investig Drugs; 2015; 24(8):1045-58. PubMed ID: 26098203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]